LEXARIA BIOSCIENCE CORP. Amortization of Leased Asset
LEXARIA BIOSCIENCE CORP. (LEXX) reported Amortization of Leased Asset of $64.56 thousand for the 9-month period ending 2022-05-31, per its 10-Q filed 2022-07-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfLeasedAsset · last filed 2022-07-14
| Period end | Amortization of Leased Asset 9 month | Amortization of Leased Asset 12 month |
|---|---|---|
| 2022-05-31 | $64.56K 10-Q · filed 2022-07-14 | |
| 2021-08-31 | $35.88K 10-Q · filed 2022-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |